Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Invitae Corp (NY: NVTA )

33.03 USD -1.11 (-3.25%)
Streaming Delayed Price Updated: 9:33 AM EST, Mar 8, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Stories about Invitae Corp

< Previous 1 2 3 4 5 6 7 8 9
...
16 17 Next >
Does Invitae Have a Path to Profitability?
Top-line growth should help the company grow its bottom line eventually. 
Tags NVTA Market News
From Motley Fool
Why Invitae Stock Tumbled Again Today
The overall market sell-off dragged Invitae's shares down. 
Tags Market News NVTA
From Motley Fool
Should You Buy Invitae Stock?
The past 12 months have been a wild ride for the genetic testing company's stock, with a sub-$10 low and a high of more than $60. 
Tags CRSP Market News TSLA
From Motley Fool
Why Invitae Stock Fell Today
The medical genetics company was pulled down by a broader sell-off of growth stocks. 
Tags Market News NVTA
From Motley Fool
Analysts Predict 10% Upside For ANEW
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and... 
Tags ETFs
From ETF Channel
The Brave New Genomic World
It is not just genomics changing the pharmaceutical sector. AI is also providing a helping hand to accelerate the genomics revolution. 
Tags Stocks / Equities Market News Pharma/Biotech
From Blogs - TalkMarkets
First Week of NVTA September 17th Options Trading
Investors in Invitae Corp (NVTA) saw new options begin trading this week, for the September 17th expiration. One of the key data points that goes into the price an option buyer is willing to pay, is... 
Tags Stocks
From Market News Video
Stocks With Rising Relative Price Strength: Invitae
Invitae shows rising price performance, earning an upgrade to its IBD Relative Strength Rating from 79 to 82. 
From Investor's Business Daily
Why Invitae Stock Is Falling Today
The healthcare company is diving along with the market. 
Tags Market News NVTA
From Motley Fool
Why Invitae Stock Fell 11.1% Today
There's nothing to be alarmed about. 
Tags Market News NDAQ NVTA
From Motley Fool
7 Growth Stocks to Plant in Your Portfolio
<p><a rel="nofollow" href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice & Trading Tips</a></p> <p>Many investors fear growth stocks because of increased volatility and... 
Tags WORK BABA TWTR
From InvestorPlace
Why Veru, Invitae And More Are Moving Today
Community Health Systems (NYSE: CYH) shares are trading higher after the company reported better-than-expected fourth-quarter sales ... 
Tags CYH Market News Small Cap
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For February 18, 2021
Upgrades According to Ladenburg Thalmann, the prior rating for Invitae Corp (NYSE:NVTA) was changed from Neutral to Buy. ... 
Tags STM NVTA LMNL
From Benzinga
The Daily Biotech Pulse: Lily-Rigel Licensing Deal, vTv Starts Early Stage Psoriasis Study, Immunic Data Readout
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ... 
Tags Small Cap PFE IMNM
From Benzinga
Why Invitae's Q4 Results Didn't Fire Up Investors
The company's revenue soared, but so did its expenses. 
Tags NVTA Market News
From Motley Fool
Invitae (NVTA) Q4 2020 Earnings Call Transcript
NVTA earnings call for the period ending December 31, 2020. 
Tags Market News NVTA
From Motley Fool
Recap: Invitae Q4 Earnings
Shares of Invitae (NYSE:NVTA) fell in after-market trading after the company reported Q4 results. Quarterly Results Earnings per ... 
Tags NVTA BZI/Recaps Benzinga
From Benzinga
Investors Snatch NVTA 7.5% Cheaper Than Its Secondary Stock Offering
Looking back to 27 days ago, Invitae Corp (NVTA) priced a 7,766,990 share secondary stock offering at $51.50 per share. Buyers in that offering made a considerable investment into the company,... 
Tags Stocks
From Market News Video
Earnings Scheduled For February 17, 2021
Companies Reporting Before The Bell • Analog Devices (NASDAQ:ADI) is projected to report quarterly earnings at $1.32 ... 
Tags CPS SFL LOPE
From Benzinga
Noteworthy Tuesday Option Activity: NVTA, CVM, SEDG
Looking at options trading activity among components of the Russell 3000 index, there is noteworthy activity today in Invitae Corp (NVTA), where a total volume of 21,926 contracts has been traded thus... 
Tags Stocks
From Market News Video
7 Stocks to Buy to Get the Most Out of More Stimulus
<p><a rel="nofollow" href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice & Trading Tips</a></p> <p>Buy-and-hold investing in strong stocks could be a winning long-term... 
Tags ARKK GDX TDOC
From InvestorPlace
Pacific Biosciences (PACB) Stock: Is This Biotech Stock The Next Illumina?
Tags Market News
From StockMarket.com
3 Healthcare Stocks I'd Buy Right Now
Two innovative small companies with scorching growth and one bargain biotech. 
Tags PGNY Market News NVTA
From Motley Fool
The Week Ahead In Biotech: FDA Decision On G1 Therapeutics, Earnings In The Mix For Light Calendar Week
Biotech stocks advanced in the week ended Feb. 12, thanks to broader market strength and company-specific catalysts. Small and mid-cap ... 
Tags WST FDA GMED
From Benzinga
Looking For Biotech Stocks To Buy Now? 4 Names To Know
Tags Market News
From StockMarket.com
SoftBank To Invest $900M In Pacific Biosciences - WSJ
SoftBank Group Corp(OTCMKTS: SFTBY) willreportedly invest $900 millionintoPacific Biosciences of California ... 
Tags Offerings Tech SFTBF
From Benzinga
Inside Actively Managed Equity ETFs - A Topic Of Increasing Importance
Today’s analysis covers sevenal actively managed ETFs. A handful have had tremendous success in performance and asset capture. Most, thus far, have not. Seven ETFs are compared to SPY as a benchmark... 
Tags ETFs
From Blogs - TalkMarkets
Healthcare Expert: These Are the Most Important Lessons From the Pandemic
The takeaways go beyond coronavirus testing, treatments, and vaccines. 
Tags NVTA Market News TDOC
From Motley Fool
A Healthcare Expert Tells Us What's Next for Digital Health
Many healthcare players went back to the drawing board in 2020. What trends will drive them forward? 
Tags NVTA AMZN TMO
From Motley Fool
Looking For The Best Biotech Stocks To Buy? 1 Reported Earnings Today
Tags Market News
From StockMarket.com
< Previous 1 2 3 4 5 6 7 8 9
...
16 17 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.